Table 3.

Clinicopathological features according to SMARCB1/INI1 immunohistochemical expression.

	SMARCB1/INI1 + (n = 52)	SMARCB1/INI +/− (n = 37)	p-Value
Gender (N, %) Male Female
	28 (53.8%)	23 (62.2%)	0.516
	24 (46.2%)	14 (37.8%)
Age (median, range in years)	61.5 (28–86)	59 (17–79)	0.511
Age (N, %)
≤60 years	22 (42.3%)	20 (54.1%)	0.291
>60 years	30 (57.7%)	17 (45.9%)
Tumor size (N, %)
<5 cm	20 (38.5%)	16 (43.2%)
≥5 cm	20 (38.5%)	19 (51.4%)	0.818
Not available	12 (23%)	2 (5.4%)
Tumor localization
Cervical–thoracic–lumbar region	20 (38.5%)	23 (62.2%)	0.033
Sacrococcygeal region	32 (61.5%)	14 (37.8%)
Surgical margin
Adequate	30 (57.7%)	15 (40.5%)
Inadequate	8 (15.3%)	17 (46%)	0.007
Not available	14 (27%)	5 (13.5%)
Ki-67 index (median, range in percentage)	3 (1–12%)	3 (1–9%)	0.459
Ki-67 index (N, %)
≤3%	26 (50%)	17 (46%)
>3%	24 (46.2%)	13 (35%)	0.817
Not evaluable	2 (3.8%)	7 (19%)

Statistically significant p values are shown in red color.